Cullinan Therapeutics, Inc.
USD18.72
+0.30 (+1.62%)
CEO
Nadim Ahmed
IPO Date
2021-01-08
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$18.62
Prev. Close
$18.42
Day Low
$18.34
Day High
$18.82
52W Low
$5.68
52W High
$19.43
Market Cap
$1.15B
Volume
0.10M
| 25,319 |
| $13.55 |
| 18 Jun 2026 | Webster Stephen W | director | A-Award | Acquired | 25,319 | $13.55 |
| 18 Jun 2026 | Allen Andrew R | director | A-Award | Acquired | 21,781 | $13.55 |
| 18 Jun 2026 | Thistle Mary | director | A-Award | Acquired | 25,319 | $13.55 |
| 18 Jun 2026 | Doyle Mittie | director | A-Award | Acquired | 21,781 | $13.55 |
| 6 May 2026 | Michaelson Jennifer | Chief Scientific Officer | M-Exempt | Acquired | 4,000 | $4.30 |
| 6 May 2026 | Michaelson Jennifer | Chief Scientific Officer | S-Sale | Disposed | 7,800 | $14.60 |
| 6 May 2026 | Michaelson Jennifer | Chief Scientific Officer | S-Sale | Disposed | 200 | $15.58 |
| 6 May 2026 | Michaelson Jennifer | Chief Scientific Officer | M-Exempt | Disposed | 4,000 | $4.30 |